Aminex Therapeutics, Inc. funding
Aminex Therapeutics, Inc., a biotechnology company based in Kenmore, WA, filed a Form D with the SEC on December 5, 2025 and reported $15.1M raised of a $30M offering.
Amount raised$15.1M
Offering size$30M
Filed with the SECDecember 5, 2025
First saleOctober 25, 2022
IndustryBiotechnology
SecuritiesEquity
LocationKenmore, WA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far162
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 5